From: Proton beam therapy for hepatocellular carcinoma with bile duct invasion
Basic characteristics | Central (n = 11) | Peripheral (n = 4) | P value |
---|---|---|---|
Age (years), median [IQR] | 69.0 [63.5, 80.0] | 75.5 [70.5, 78.5] | 0.69 |
Sex (Male / Female) | 8 (72.7%) / 3 (27.3%) | 4 (100.0%) / 0 (0.0%) | 0.66 |
Performance status score (0 / 1–3) | 4 (36.4%) / 6 (46.6%) | 2 (50.0%) / 2 (50.0%) | 0.36 |
Child (A / B,C) | 5 (45.5%) / 6 (54.5%) | 3 (75.0%) / 1 (25.0%) | 0.56 |
Etiology (HBV / HCV / NBNC) | 2 (18.2%) / 6 (54.5%) / 3 (27.3%) | 3 (75.0%) / 1 (25.0%) / 0 (0.0%) | 0.55 |
Tumor characteristics | Â | Â | Â |
Size, median [IQR], cm | 4.0 [3.5, 6.3] | 4.4 [3.2, 6.0] | 0.94 |
Number (Solitary / Multiple) | 7 (63.6%) / 4 (36.4%) | 4 (100.0%) / 0 (0.0%) | 0.45 |
Prior treatment history (No / Yes) | 5 (45.5%) / 6 (54.5%) | 2 (50.0%) / 2 (50.0%) | 0.73 |
BDTT (No / Yes) | 0 (0.0%) / 11 (100.0%) | 2 (50.0%) / 2 (50.0%) | 0.10 |
AFP, median [IQR], ng/ml | 57.0 [21.6, 315.5] | 179.7 [6.3, 3130.7] | 1.00 |
DCP, median [IQR], mAU/ml | 48.0 [20.0, 612.0] | 27.0 [17.5, 11731.8] | 0.84 |